COVID-19 has emphasized an urgent need to modernize how we manufacture medicines. Americans would benefit most from improving how we produce medicines, making them cheaper, more effective and more accessible. This wouldn’t be the first time a pandemic threat inspired innovation. The threat of the H5N1 pandemic spurred modernization of […]